It takes a multidisciplinary view to understand the complicated world of glycoscience, but understanding has been made easier thanks to newly developed GlyGen. A $10 million grant from the National Institutes of Health has funded GlyGen, a glycoscience informatics portal created by the partnership of University of Georgia and George Washington University.
“GlyGen brings disparate information together in a unified way, reducing the learning curve for those new to glycoscience,” according to the University of Georgia.
The potential of this new resource is incredible, as it will allow scientists to compare data and make connections in an environment that provides context. Promising areas for breakthroughs based on glycoscience are in understanding cancer, infectious diseases and issues involving development and nutrition.
The data integration team is led by Raja Mazumder, co-principal investigator and associate professor of biochemistry and molecular medicine at George Washington University’s School of Medicine and Health Sciences.
The more we know as healthcare providers, the more powerful and effective treatment becomes.
Call to Action: Ready to learn more about the potential of GlyGen? Visit their website or take advantage of TrialSite News’ Network Matching services.